Neuronetics Investor Relations Material
Latest events
Q1 2025
Neuronetics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Neuronetics Inc
Access all reports
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. It offers NeuroStar advanced therapy system that enables physicians to provide office-based treatments for adult patients suffering from major depressive disorder (MDD); and maintains a registry of clinical outcomes of MDD treatment using the system. The company was founded in 1997 and is headquartered in Malvern, Pennsylvania.
Key slides for Neuronetics Inc
Q1 2025
Neuronetics Inc
Q2 2024
Neuronetics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
STIM
Country
🇺🇸 United States